Convert pharma
Convert secures €13.6m grant to develop targeted chemo for oxygen-deprived tumours
March 9, 2018Medical Communications, Research and Development Belgium, Cancer, Convert pharma, chemotherapy, pharma
Belgium’s Convert Pharmaceuticals has secured a €13.6 million grant for initial development efforts on a new targeted chemotherapy drug which …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
